Project Details
| Short title | A Randomized, Open Label Phase II Study of OSI-211 vs Topotecan in Patients with Relapsed Epothelial Ovarian Cancer |
|---|---|
| Status | Finished |
| Effective start/end date | 1/09/02 → 31/08/05 |
Funding
- OSI PHARMACEUTICALS INC
A Randomized, Open Label Phase II Study of OSI-211 vs Topotecan in Patients with Relapsed Epothelial Ovarian Cancer
- Poole, Christopher (Principal Investigator)